Uncategorized Archives - Page 4 of 6 - HealthCare Royalty

April 2, 2020

RedHill Biopharma Completes Acquisition of Movantik^® from AstraZeneca

February 25, 2020

RedHill Biopharma Acquires Rights to Movantik^® from AstraZeneca

February 25, 2020

RedHill Biopharma Enters $115 Million Non-Dilutive Financing Agreement with HealthCare Royalty Partners

October 25, 2019

GSK receives prestigious Prix Galien USA award for SHINGRIX

September 16, 2019

Karyopharm Enters Into Royalty Agreement with Healthcare Royalty Partners for up to $150 Million

March 6, 2019

Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA™ for $30 Million Gross Proceeds

January 7, 2019

Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners

November 5, 2018

Grünenthal Acquires Global Rights for Qutenza^®

November 2, 2018

U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)

October 23, 2018

Gary A. Lyons Joins HealthCare Royalty Partners Senior Advisor Board